Microchips in Medicine Market Share

  • Report ID: 3734
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Microchips in Medicine Market Share

North American Market Forecast

Microchips in Medicine market in North America is predicted to account for the largest share of 35% by 2036 impelled by the growing spending in healthcare. In comparison to other countries, the United States spends a lot more money on healthcare, and personal healthcare spending in the country increased by an average of over 4% year between 2014 and 2020. This may significantly lead to an increase in demand for advanced medical technologies that rely on microchips which would offer a way to monitor and control diseases more efficiently. In 2021, the United States spent more than 2% on health care, amounting to roughly USD 4 trillion per person.

Europe Market Forecast

The Europe microchips in medicine market is estimated to be the second largest, during the forecast timeframe led by the rapid and early adoption of microchips in healthcare. For instance, the use of futuristic microchips implanted under the skin of the hand has been implemented by thousands of Swedes in 2018. There are approximately 2,900 Swedes who have chosen to implant microchips between their thumbs and index fingers.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3734
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of microchips in medicine is evaluated at USD 1.13 Billion.

The microchips in medicine market size was over USD 1.07 Billion in 2023 and is likely to exceed USD 2.45 Billion by the end of 2036, witnessing over 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing popularity of microchip implants in healthcare to improve patient outcomes and the increasing trend of digitalization in healthcare are the major factors driving the growth of the market.

North America industry is predicted to account for the largest share of 35% by 2036, impelled by growing spending in healthcare in the region.

Thermo Fisher Scientific Inc., Applied Microarrays Inc., RELX Group, QIAGEN, Agilent Technologies, Inc., INTROMEDIC, Otsuka America Pharmaceutical, Inc., Medtronic Plc, Illumina, Inc., Bio-Rad Laboratories, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample